Liquid biopsy-guided kidney-sparing management in upper tract urothelial carcinoma: from preoperative risk stratification to perioperative surveillance. [PDF]
Front OncolYu D +5 more
europepmc +1 more source
Liquid Biopsy Biomarkers for Predicting and Monitoring Immunotherapy Response in Lung Cancer. [PDF]
Cancers (Basel)Serio VB +3 more
europepmc +1 more source
Clinical application of liquid biopsy in the diagnosis and treatment of lung cancer: taking ctDNA for example-a narrative review. [PDF]
J Thorac DisJiang Z, Cui H.
europepmc +1 more source
Diagnostic Accuracy of Blood-Based cfDNA/ctDNA Tests for Colorectal Cancer-A Systematic Review and Meta-Analysis. [PDF]
Cancers (Basel)Rose JH +6 more
europepmc +1 more source
Evidence Mapping of ctDNA Reporting in Pancreatic Ductal Adenocarcinoma: Toward a Shared Quantitative Language for ctDNA. [PDF]
Cancers (Basel)Croagh D, Aslani S.
europepmc +1 more source
Pan-Cancer Pre-Treatment ctDNA Detection Using a Highly Sensitive Tumor-Informed Assay. [PDF]
Int J Mol SciStrum S +13 more
europepmc +1 more source
Improving detection of colorectal cancer: A Bayesian approach to serial circulating tumour DNA testing following curative-intent treatment. [PDF]
Clin Transl MedPedersen SK +8 more
europepmc +1 more source
Assessment of methylated BCAT1 and IKZF1 circulating tumor DNA as a prognostic biomarker in esophagogastric adenocarcinomas. [PDF]
Dis EsophagusChan MM +9 more
europepmc +1 more source
Circulating tumor DNA as a prognostic and monitoring biomarker in urothelial cancers. [PDF]
Front OncolAragon-Ching JB, Urabe F, Yajima S.
europepmc +1 more source